ribavirin has been researched along with Caliciviridae Infections in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (54.55) | 24.3611 |
2020's | 5 (45.45) | 2.80 |
Authors | Studies |
---|---|
Dalm, VASH; de Graaf, M; Estes, MK; Ettayebi, K; Fraaij, PLA; Izquierdo-Lara, RW; Koopmans, MPG; Oude Munnink, BB; Schapendonk, CME; van Kampen, JJA; Villabruna, N | 1 |
Calderón-Hernanz, B; de Hita-Santabaya, AI; González-Morcillo, G; Riera-Oliver, J; Serrano-López de Las Hazas, J | 1 |
Carlsson, B; Hagbom, M; Nilsdotter-Augustinsson, Å; Nordgren, J; Nyström, S; Öman, M; Ottosson, L; Ström, M; Svensson, L; Svernlöv, R | 1 |
Albuquerque, AS; Atkinson, C; Breuer, J; Brown, JR; Brown, LK; Burns, SO; Clark, I; Cudini, J; Dervisevic, S; Karim, MY; Lowe, DM; Miller, J; Moore, J; Moreira, F; Neild, P; Patel, SY; Roy, S; Ruis, C; Seneviratne, SL; Toumpanakis, C; Williams, CA; Workman, S | 1 |
Cui, Z; Du, D; Guo, Y; Hu, G; Huang, H; Li, D; Li, G; Li, T; Men, F; Shao, J; Wang, K; Zhang, L; Zhang, S; Zhang, Y; Zhao, H; Zhao, S; Zhao, Y | 1 |
Li, Y; Miao, Z; Pan, Q; Peppelenbosch, MP; Wang, Y; Yu, P | 1 |
Chang, KO; Dang, W; Felczak, K; Koopmans, MPG; Metselaar, HJ; Pan, Q; Pankiewicz, KW; Peppelenbosch, MP; Sprengers, D; Su, J; van der Laan, LJW; Wang, W; Wang, Y; Yin, Y | 1 |
Chang, KO; Chen, S; Dang, W; Ma, B; Pan, Q; Peppelenbosch, MP; Xu, L; Yin, Y | 1 |
Arias, A; Goodfellow, I; Thorne, L | 1 |
Aravinthan, A; Bandoh, BN; Cordero-Ng, AY; Curran, MD; Davies, S; Gkrania-Klotsas, E; Kumararatne, D; Liu, H; Stevenson, P; Woodward, JM; Zhang, H | 1 |
Gkrania-Klotsas, E; Kumararatne, D; Woodward, J | 1 |
2 review(s) available for ribavirin and Caliciviridae Infections
Article | Year |
---|---|
Ribavirin-resistant chronic norovirus infection-associated enteropathy in common variable immunodeficiency. Case report and review of the literature.
Topics: Caliciviridae Infections; Common Variable Immunodeficiency; Female; Humans; Inflammatory Bowel Diseases; Middle Aged; Ribavirin | 2022 |
Chronic norovirus infection and common variable immunodeficiency.
Topics: Antiviral Agents; Caliciviridae Infections; Chronic Disease; Common Variable Immunodeficiency; Diarrhea; Duodenum; Humans; Immunoglobulins; Norovirus; Ribavirin; Tomography, X-Ray Computed | 2017 |
9 other study(ies) available for ribavirin and Caliciviridae Infections
Article | Year |
---|---|
Clinical and In Vitro Evidence Favoring Immunoglobulin Treatment of a Chronic Norovirus Infection in a Patient With Common Variable Immunodeficiency.
Topics: Antiviral Agents; Caliciviridae Infections; Common Variable Immunodeficiency; Humans; Immunoglobulins; Interferon-alpha; Norovirus; Ribavirin; RNA, Viral; Virus Replication | 2022 |
Long Term Norovirus Infection in a Patient with Severe Common Variable Immunodeficiency.
Topics: Blood Group Antigens; Caliciviridae Infections; Common Variable Immunodeficiency; Gastroenteritis; Genotype; Humans; Immunodominant Epitopes; Immunoglobulins, Intravenous; Intestinal Diseases; Norovirus; Ribavirin | 2022 |
A comprehensive characterization of chronic norovirus infection in immunodeficient hosts.
Topics: Adult; Antigens, CD19; Antiviral Agents; B-Lymphocytes; Caliciviridae Infections; Cells, Cultured; Common Variable Immunodeficiency; Enterocolitis; Female; Humans; Immunocompromised Host; Male; Middle Aged; Nitro Compounds; Norovirus; Programmed Cell Death 1 Receptor; Recurrence; Ribavirin; Species Specificity; T-Lymphocytes; Thiazoles; Treatment Outcome; Up-Regulation | 2019 |
Antiviral effect of copper chloride on feline calicivirus and synergy with ribavirin in vitro.
Topics: Animals; Antiviral Agents; Caliciviridae Infections; Calicivirus, Feline; Cat Diseases; Cats; Cell Line; Copper; Drug Synergism; In Vitro Techniques; Ribavirin | 2020 |
2'-Fluoro-2'-deoxycytidine inhibits murine norovirus replication and synergizes MPA, ribavirin and T705.
Topics: Amides; Animals; Antiviral Agents; Caliciviridae Infections; Cell Line; Deoxycytidine; Humans; Mice; Mycophenolic Acid; Norovirus; Pyrazines; RAW 264.7 Cells; Ribavirin; Virus Replication | 2020 |
Inhibition of Calcineurin or IMP Dehydrogenase Exerts Moderate to Potent Antiviral Activity against Norovirus Replication.
Topics: Antiviral Agents; Calcineurin; Calcineurin Inhibitors; Caliciviridae Infections; Cell Line; Cyclosporine; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Mycophenolic Acid; Norovirus; Ribavirin; Tacrolimus; Tacrolimus Binding Protein 1A; Virus Replication | 2017 |
Nitazoxanide Inhibits Human Norovirus Replication and Synergizes with Ribavirin by Activation of Cellular Antiviral Response.
Topics: Antiviral Agents; Caco-2 Cells; Caliciviridae Infections; Cell Line; Cell Line, Tumor; Drug Synergism; Gastroenteritis; HEK293 Cells; Humans; Interferon Regulatory Factor-1; Intestines; Janus Kinases; Nitro Compounds; Norovirus; Organoids; Replicon; Ribavirin; STAT1 Transcription Factor; Thiazoles; Virus Replication | 2018 |
Favipiravir elicits antiviral mutagenesis during virus replication in vivo.
Topics: Amides; Animals; Antiviral Agents; Caliciviridae Infections; Cells, Cultured; Feces; Male; Mice, Inbred C57BL; Mutagenesis; Mutation Rate; Norovirus; Pyrazines; Ribavirin; RNA, Viral; Serial Passage; Virus Replication | 2014 |
The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency.
Topics: Adult; Aged; Antiviral Agents; Biopsy; Caliciviridae Infections; Case-Control Studies; Chronic Disease; Cohort Studies; Common Variable Immunodeficiency; Duodenum; Feces; Female; Humans; Intestinal Diseases; Intestine, Small; Male; Middle Aged; Norovirus; Ribavirin; RNA, Viral | 2015 |